Cargando…
Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ
INTRODUCTION: Over 19% of deceased organ donors are labeled increased risk for disease transmission (IRD) for viral blood‐borne disease transmission. Many potential organ recipients need to decide between accepting an IRD organ offer and waiting for a non–IRD organ. METHODS: Using machine learning a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285951/ https://www.ncbi.nlm.nih.gov/pubmed/31541522 http://dx.doi.org/10.1111/tid.13181 |
_version_ | 1784747899834335232 |
---|---|
author | Mark, Ethan Goldsman, David Keskinocak, Pinar Sokol, Joel |
author_facet | Mark, Ethan Goldsman, David Keskinocak, Pinar Sokol, Joel |
author_sort | Mark, Ethan |
collection | PubMed |
description | INTRODUCTION: Over 19% of deceased organ donors are labeled increased risk for disease transmission (IRD) for viral blood‐borne disease transmission. Many potential organ recipients need to decide between accepting an IRD organ offer and waiting for a non–IRD organ. METHODS: Using machine learning and simulation, we built transplant and waitlist survival models and compared the survival for patients accepting IRD organ offers or waiting for non–IRD organs for the heart, liver, and lung. The simulation consisted of generating 20 000 different scenarios of a recipient either receiving an IRD organ or waiting and receiving a non–IRD organ. RESULTS: In the simulations, the 5‐year survival probabilities of heart, liver, and lung recipients who accepted IRD organ offers increased on average by 10.2%, 12.7%, and 7.2%, respectively, compared with receiving a non–IRD organ after average wait times (190, 228, and 223 days, respectively). When the estimated waitlist time was at least 5 days for the liver, and 1 day for the heart and lung, 50% or more of the simulations resulted in a higher chance of 5‐year survival when the patient received an IRD organ versus when the patient remained on the waitlist. We also developed a simple equation to estimate the benefits, in terms of 5‐year survival probabilities, of receiving an IRD organ versus waiting for a non–IRD organ, for a particular set of recipient/donor characteristics. CONCLUSION: For all three organs, the majority of patients are predicted to have higher 5‐year survival accepting an IRD organ offer compared with waiting for a non–IRD organ. |
format | Online Article Text |
id | pubmed-9285951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92859512022-07-19 Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ Mark, Ethan Goldsman, David Keskinocak, Pinar Sokol, Joel Transpl Infect Dis Original Articles INTRODUCTION: Over 19% of deceased organ donors are labeled increased risk for disease transmission (IRD) for viral blood‐borne disease transmission. Many potential organ recipients need to decide between accepting an IRD organ offer and waiting for a non–IRD organ. METHODS: Using machine learning and simulation, we built transplant and waitlist survival models and compared the survival for patients accepting IRD organ offers or waiting for non–IRD organs for the heart, liver, and lung. The simulation consisted of generating 20 000 different scenarios of a recipient either receiving an IRD organ or waiting and receiving a non–IRD organ. RESULTS: In the simulations, the 5‐year survival probabilities of heart, liver, and lung recipients who accepted IRD organ offers increased on average by 10.2%, 12.7%, and 7.2%, respectively, compared with receiving a non–IRD organ after average wait times (190, 228, and 223 days, respectively). When the estimated waitlist time was at least 5 days for the liver, and 1 day for the heart and lung, 50% or more of the simulations resulted in a higher chance of 5‐year survival when the patient received an IRD organ versus when the patient remained on the waitlist. We also developed a simple equation to estimate the benefits, in terms of 5‐year survival probabilities, of receiving an IRD organ versus waiting for a non–IRD organ, for a particular set of recipient/donor characteristics. CONCLUSION: For all three organs, the majority of patients are predicted to have higher 5‐year survival accepting an IRD organ offer compared with waiting for a non–IRD organ. John Wiley and Sons Inc. 2019-10-09 2019-12 /pmc/articles/PMC9285951/ /pubmed/31541522 http://dx.doi.org/10.1111/tid.13181 Text en © 2019 The Authors. Transplant Infectious Disease published by Wiley Periodicals, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Mark, Ethan Goldsman, David Keskinocak, Pinar Sokol, Joel Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title | Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title_full | Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title_fullStr | Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title_full_unstemmed | Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title_short | Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
title_sort | using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285951/ https://www.ncbi.nlm.nih.gov/pubmed/31541522 http://dx.doi.org/10.1111/tid.13181 |
work_keys_str_mv | AT markethan usingmachinelearningtoestimatesurvivalcurvesforpatientsreceivinganincreasedriskfordiseasetransmissionheartliverorlungversuswaitingforastandardorgan AT goldsmandavid usingmachinelearningtoestimatesurvivalcurvesforpatientsreceivinganincreasedriskfordiseasetransmissionheartliverorlungversuswaitingforastandardorgan AT keskinocakpinar usingmachinelearningtoestimatesurvivalcurvesforpatientsreceivinganincreasedriskfordiseasetransmissionheartliverorlungversuswaitingforastandardorgan AT sokoljoel usingmachinelearningtoestimatesurvivalcurvesforpatientsreceivinganincreasedriskfordiseasetransmissionheartliverorlungversuswaitingforastandardorgan |